HEALTH — Nightingale Health Oyj Cashflow Statement
0.000.00%
Last trade - 00:00- €129.95m
- €82.31m
- €4.69m
Annual cashflow statement for Nightingale Health Oyj, fiscal year end - June 30th, EUR millions except per share, conversion factor applied.
R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.72 | -16.1 | -18.1 | -17.5 | -18.5 |
| Depreciation | |||||
| Non-Cash Items | 4.23 | 6.01 | 3.28 | 1.79 | 0.949 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.17 | -1.63 | 0.784 | -0.892 | -0.89 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.87 | -7.47 | -7.33 | -8.41 | -10.1 |
| Capital Expenditures | -0.895 | -1.37 | -0.833 | -4.59 | -4.15 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -5.71 | -6.95 | -3.58 | -20.9 | 13.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.61 | -8.32 | -4.41 | -25.5 | 9.46 |
| Financing Cash Flow Items | 122 | 0.288 | 0.185 | -0.716 | -0.27 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 121 | -2.86 | -2.58 | -2.83 | -1.58 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 113 | -18.5 | -14.6 | -37 | -2.36 |